33 results

• Wegovy Lawsuit Alleges Vision Loss Side Effects Concealed by Novo Nordisk

  May 6, 2025

  Irvin Jackson

  A Wegovy lawsuit claims the weight loss drug's side effects caused him to suffer vision problems after a year of injections.

• Ozempic Blindness Lawsuit Claims Drug Caused NAION Side Effects

  April 28, 2025

  Irvin Jackson

  A new lawsuit claims that the diabetes and weight loss drug, Ozempic, caused a woman to lose vision in her left eye.

• Study Suggests There May Not Be a Link Between Ozempic, Mounjaro and Post-Surgery Aspiration Pneumonia

  March 12, 2025

  Irvin Jackson

  New findings appear to contradict warnings that GLP-1 drugs, like Ozempic and Mounjaro, can increase the risk of post-surgical aspiration due to a lack of gastric emptying.

• Victoza Caused Side Effects in 80% of Children, But Helped Them Lose Weight: Study

  February 12, 2025

  Irvin Jackson

  Most children given Victoza for about a year suffered gastrointestinal adverse events, according to a study that also concludes the drug could help some obese children significantly reduce their BMI.

• GLP-1 Drug Prescriptions Have Doubled in Recent Years, But Many Users Quit Soon After Starting

  February 10, 2025

  Irvin Jackson

  Two new studies mark the rapid rise in Ozempic, Wegovy, Zepbound and other GLP-1 medication prescriptions in recent years, but warns that a variety of factors, including side effects, age, income and weight loss, often make new users quit within a year.

• Vision Problems From Ozempic, Other GLP-1 Drugs May Result From Rapid Correction of Hyperglycemia: Study

  February 6, 2025

  Irvin Jackson

  A new study raises questions about whether Ozempic vision loss is caused by toxic ingredients in the drug, or the body's reaction to quickly dropping blood sugar levels.

• Side Effects of Ozempic, Other GLP-1 Drugs Are Mixed, With Net Benefits Overall: Study

  January 22, 2025

  Irvin Jackson

  A new study attempts to categorize the benefits and risks of drugs like Ozempic and Mounjaro, finding that they decrease the risk of many metabolic health problems due to the weight lost, while warning of potential gastrointestinal problems such as stomach paralysis, and an increased risk of acute pancreatitis.

• EU Launches Investigation Into Ozempic Vision Loss Problems

  December 23, 2024

  Irvin Jackson

  Following nearly 20 reports of vision problems from Ozempic or Wegovy since a study was published in July 2024, Danish health officials are calling for an EU investigation into the safety of semaglutide-based drugs.

• Ozempic NAION Vision Loss Risks Confirmed in Another Study

  December 16, 2024

  Irvin Jackson

  A Danish study warns that using Ozempic and Wegovy could double the risk of a condition known to cause vision changes and blindness.

• Master Complaint Outlines Allegations in Ozempic, Wegovy, Mounjaro Lawsuits in MDL

  November 15, 2024

  Irvin Jackson

  Plaintiffs pursuing GLP-1 injury lawsuits have filed a Master Complaint outlining common allegations being pursued against Novo Nordisk and Eli Lilly over their diabetes and weight loss drugs, including Ozempic, Wegovy, Mounjaro and others.